Medivolve Inc. Stock

MEDVF

CA58503M4083

Advanced Medical Equipment & Technology

Market Closed - OTC Markets 14:50:30 2026-08-10 EDT			5-day change	1st Jan Change
0.000100 ^USD	-.--%		-.--%	+9,900.00%

05-11	Osc reaches settlements with Stan Bharti and Neil Said, former executives of Medivolve Inc.	RE
24-08-30	Medivolve Inc. Announces Resignation of David Preiner as Chief Executive Officer	CI

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Market Cap	233K 164K 147K 136K 124K 15.56M 237K 1.64M 641K 8.12M 617K 604K 25.98M	P/E 2022	-0.19x	P/E 2023	-0.02x
Enterprise Value	898K 633K 565K 525K 477K 59.92M 914K 6.3M 2.47M 31.27M 2.37M 2.32M 100M	EV / Sales 2022	22,007x	EV / Sales 2023	1,535,308x
Free-Float	94.14%	Yield 2022 *	-	Yield 2023	-

05-11	Osc reaches settlements with Stan Bharti and Neil Said, former executives of Medivolve Inc.	RE
24-08-30	Medivolve Inc. Announces Resignation of David Preiner as Chief Executive Officer	CI
24-08-30	Medivolve Inc. Announces Resignation of David Preiner as President	CI
24-05-31	Medivolve Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-04-01	Medivolve Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-04-01	Medivolve Inc. Auditor Raises 'Going Concern' Doubt	CI
24-01-15	Medivolve Inc. Announces Resignation of Peter Michel as Chief Financial Officer	CI
24-01-15	Medivolve Inc. Announces Management Changes	CI
23-11-16	Medivolve Inc. Announces the Resignation of Wen Ye as Board of Director	CI
23-11-14	Medivolve Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-11-06	Medivolve Inc. Announces the Resignation of Beverley Richardson from its Board of Directors	CI
23-08-13	Medivolve Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-05-15	Medivolve Inc. Establishes Medivolve Management Services, LLC in Puerto Rico	CI

24-08-30	Medivolve Announces Management Changes	AQ
24-02-12	Medivolve Announces Change of Auditor	AQ
24-01-15	Medivolve Announces Telehealth Platform Development Contract and Change of Officers and Directors	AQ
23-11-16	Medivolve Announces Change of Auditor and Board Changes	AQ
23-11-06	Medivolve Announces Board Changes	AQ

Current year	0		0
1 year	0		0
3 years	0		0.05
5 years	0		3
10 years	0		10.35

Date	Insider	Type	Main position	Quantity	% Market Cap.
4/4/24	David Preiner	Tax	Chief Executive Officer	6,203,788	22.9606%
2/21/24	Douglas Sommerville	Option		750,000	2.7758%
2/21/24	Douglas Sommerville	Buy		750,000	2.7758%

Medivolve Inc. Stock

Stocks

MEDVF

CA58503M4083

Advanced Medical Equipment & Technology

Valuation: Medivolve Inc.

Chart: Medivolve Inc.

Latest news: Medivolve Inc.

Press Releases: Medivolve Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Medivolve Inc.

Latest insider transactions

Medical Software & Technology Services

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MEDIVOLVE INC.	-.--%	-.--%	-	-	2.7K
Average	-.--%
Weighted average by Cap.	-.--%

	2022	2023
Net sales	37.18 26.19 23.37 21.72 19.76 2.48K 37.85 260.94 102.1 1.29K 98.26 96.18 4.14K	0.69 0.48 0.43 0.4 0.36 45.8 0.7 4.82 1.89 23.89 1.81 1.78 76.46
Net income	-18.37M -12.94M -11.55M -10.73M -9.76M -1.23B -18.7M -129M -50.44M -639M -48.54M -47.52M -2.05B	-16.46M -11.59M -10.35M -9.62M -8.75M -1.1B -16.75M -116M -45.2M -573M -43.5M -42.58M -1.83B
Net Debt	-2.64M -1.86M -1.66M -1.55M -1.41M -176M -2.69M -18.57M -7.26M -92.07M -6.99M -6.84M -295M	665K 468K 418K 389K 353K 44.36M 677K 4.67M 1.83M 23.15M 1.76M 1.72M 74.07M